221 related articles for article (PubMed ID: 3012534)
1. Platelet-derived growth factor modulates epidermal growth factor receptors by a mechanism distinct from that of phorbol esters.
Olashaw NE; O'Keefe EJ; Pledger WJ
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3834-8. PubMed ID: 3012534
[TBL] [Abstract][Full Text] [Related]
2. Heterologous regulation of EGF receptors in fibroblastic cells.
Olashaw NE; Pledger WJ
J Cell Biochem; 1987 Jun; 34(2):143-9. PubMed ID: 3496345
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.
Wharton W; Leof E; Pledger WJ; O'Keefe EJ
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5567-71. PubMed ID: 6291052
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid.
Winston JT; Olashaw NE; Pledger WJ
J Cell Biochem; 1991 Sep; 47(1):79-89. PubMed ID: 1658015
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654.
Davis RJ; Czech MP
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4080-4. PubMed ID: 2987962
[TBL] [Abstract][Full Text] [Related]
6. sn-1,2-Dioctanoylglycerol. A cell-permeable diacylglycerol that mimics phorbol diester action on the epidermal growth factor receptor and mitogenesis.
Davis RJ; Ganong BR; Bell RM; Czech MP
J Biol Chem; 1985 Feb; 260(3):1562-6. PubMed ID: 2981862
[TBL] [Abstract][Full Text] [Related]
7. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of epidermal growth factor receptor threonine 654 phosphorylation by platelet-derived growth factor in protein kinase C-deficient human fibroblasts.
Davis RJ; Czech MP
J Biol Chem; 1987 May; 262(14):6832-41. PubMed ID: 3106361
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermal growth factor binding to Swiss 3T3 cells by human platelet release-products.
Brown KD; Blakeley DM; MacDonald M
Biosci Rep; 1983 Jul; 3(7):659-66. PubMed ID: 6313091
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells.
Collins MK; Sinnett-Smith JW; Rozengurt E
J Biol Chem; 1983 Oct; 258(19):11689-93. PubMed ID: 6311820
[TBL] [Abstract][Full Text] [Related]
11. Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding.
Zachary I; Sinnett-Smith JW; Rozengurt E
J Cell Biol; 1986 Jun; 102(6):2211-22. PubMed ID: 3011811
[TBL] [Abstract][Full Text] [Related]
12. Transmodulation of epidermal growth factor binding by platelet-derived growth factor and 12-O-tetradecanoylphorbol-13-acetate is not sodium-dependent in Balb/c/3T3 cells.
Olson JE; Pledger WJ
J Biol Chem; 1990 Feb; 265(4):1847-51. PubMed ID: 2298725
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
Bowen-Pope DF; Dicorleto PE; Ross R
J Cell Biol; 1983 Mar; 96(3):679-83. PubMed ID: 6300138
[TBL] [Abstract][Full Text] [Related]
14. Tumor promoter enhances mitogenesis by PDGF with little effect on PDGF binding.
Eide BL; Krebs EG; Ross R; Pike LJ; Bowen-Pope DF
J Cell Physiol; 1986 Feb; 126(2):254-8. PubMed ID: 3003126
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor stimulates formation of inositol phosphates in BALB/c/3T3 cells pretreated with cholera toxin and isobutylmethylxanthine.
Olashaw NE; Pledger WJ
J Biol Chem; 1988 Jan; 263(3):1111-4. PubMed ID: 2447085
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the epidermal growth factor receptor by brain-derived growth factor in Swiss mouse 3T3 cells.
Huang SS; Lokeshwar VB; Huang JS
J Cell Biochem; 1988 Mar; 36(3):209-21. PubMed ID: 3379102
[TBL] [Abstract][Full Text] [Related]
17. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
18. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
Friedman B; Frackelton AR; Ross AH; Connors JM; Fujiki H; Sugimura T; Rosner MR
Proc Natl Acad Sci U S A; 1984 May; 81(10):3034-8. PubMed ID: 6328489
[TBL] [Abstract][Full Text] [Related]
19. BALB/c-3T3 fibroblasts resistant to growth inhibition by beta interferon exhibit aberrant platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor signal transduction.
Mundschau LJ; Faller DV
Mol Cell Biol; 1991 Jun; 11(6):3148-54. PubMed ID: 1645446
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of fibroblasts to epidermal growth factor is related to cyclic AMP concentration.
Olashaw NE; Leof EB; O'Keefe EJ; Pledger WJ
J Cell Physiol; 1984 Mar; 118(3):291-7. PubMed ID: 6321523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
